Search

everythinglearnresearchcommunity

for

Search:↓

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

DA-9401 helps protect rat testis from finasteride damage.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.